Dr Riyaz Shah· @DrRiyazShah · X·· 14 hours agoScore70
Body
Great DeLLphi-305 discussion by @StephenVLiu ; let’s not forget the drop off post induction; seems to trump lurbi; ICANS and CRS noted but manageable. #ESMO26
49 views · 0 likes · 0 reposts · 0 replies
Conference abstracts
LBA3matched by Presidential Symposium I
Tarlatamab plus durvalumab (durva) vs durva as 1L maintenance (1LM) therapy following durva, platinum, and etoposide (1L durva + EP) in extensive-stage small cell lung cancer (ES-SCLC): Primary analysis of the phase 3 DeLLphi-305 trial
https://esmocongress.esmo.orgSource: Dr Riyaz Shah · x.com